Inside SURPASS: ARPA-H's Bid to Redesign Clinical Trials
Dr. Dereck Mush, MD, MBA
Trialspark
Integrates technology and clinical operations to run trials at community clinics.
What they do
Trialspark is a technology-driven pharma company that runs clinical trials by turning local doctor offices into trial sites. Their software platform integrates recruitment, data collection, and operational management to reduce the time and cost of drug development.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Trial site operations
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- New York, USA
- Region
- North America
- Founded
- 2013
- Total funding
- $250M raised
Notable investors: Sequoia Capital, Thrive Capital, Casdin Capital, Section 32.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Decentralized and adaptive trial designs move from pilot to default in biotech development plans
Dr. Dereck Mush, MD, MBA
Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
The End of Phase-Gated Trials: How ARPA-H's SURPASS Program Reengineers Biomedical R&D
Dr. Dereck Mush, MD, MBA